368
Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.
 Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia: Treatment; hepatocellular carcinoma: Treatment.Disorder; arterial injection: Treatment.Route; SMANCS: Treatment.Drug; ADR: Treatment.Drug; ADR: Combination.Drug; SMANCS: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia: Treatment; hepatocellular carcinoma: Treatment.Disorder; arterial injection: Treatment.Route; SMANCS: Treatment.Drug; ADR: Treatment.Drug; ADR: Combination.Drug; SMANCS: Combination.Drug